MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication

STOCKHOLM, Feb. 7, 2024 /PRNewswire/ — Moberg Pharma ABs (OMX: MOB) marker partner in Sweden – Allderma AB, a company which specialises in the sale of over-the-counter (OTC) pharmaceuticals – has now launched sales of MOB-015 under the Terclara® brand. The interest among pharmacies has been significant for Moberg Pharma’s medication against nail fungus. ” t … Read more

Veteran Lawyer Amy Shahan Joins Nachawati Law Group

Shahan returns to Dallas-based firm as managing partner of its growing mass torts practice  DALLAS, Feb. 5, 2024 /PRNewswire/ — Nachawati Law Group is proud to announce the addition of veteran lawyer Amy Shahan, who returns to the firm as managing partner of its nationally respected mass torts practice. Ms. Shahan has devoted much of her … Read more

Closing the Cancer Care Gap with the Power of Precision Oncology

BERLIN, Feb. 4, 2024 /PRNewswire/ — According to American Cancer Society, Cancer causes about 1 in every 6 deaths globally, more than AIDS, tuberculosis, and malaria combined. Today, it is the first or second leading cause of death in most countries around the world. Technological advances in genomics have enabled the identification and improved understanding of causal factors … Read more

Registration Now for the 2024 MedDev eMarketing Summit (San Diego, CA, United States

DUBLIN, Feb. 2, 2024 /PRNewswire/ — The “2024 MedDev eMarketing Summit” conference has been added to  ResearchAndMarkets.com’s offering. Now in its 8th year, the popular MedDev eMarketing Summit is back next May 2024 in beautiful San Diego! This is a one-of-a-kind ‘TED-style’ digital marketing leadership storytelling Summit for medical device industry professionals, who are sharing their stories … Read more

INOVIO Reports Inducement Grant Under Inducement Plan

PLYMOUTH MEETING, Pa., Feb. 2, 2024 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made an equity grant to a newly hired employee under its 2022 Inducement Plan (the “Inducement Plan”). The Compensation … Read more

Hawkin Dynamics Unveils First-of-its-Kind Portable Athletic Performance & Rehabilitation Device: Hawkin TruStrength

Removing Subjectivity from the Gym and Clinic: When Force, Top Performance, and Recovery Matters, the Numbers Don’t Lie  WESTBROOK, Maine, Feb. 1, 2024 /PRNewswire/ — Today Hawkin Dynamics, an innovative, venture-backed pioneer in the sports and physical rehabilitation technology sector, announced the launch of their second product available direct-to-consumer, Hawkin TruStrength.  “We are thrilled to launch the … Read more

Heritage Management Services Expands Portfolio, Assumes Management of Two Area Communities

OMAHA, Neb., Jan. 31, 2024 /PRNewswire/ — Heritage Management Services is pleased to announce its newest venture in collaboration with American Healthcare REIT. Beginning March 1, Heritage Management Services will take the reins as the management company for two Omaha-area communities, Ridgewood and Fountain View, totaling 221 apartments. Ridgewood, located in Bennington, NE, has been … Read more

WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development

SHANGHAI, Jan. 30, 2024 /PRNewswire/ — WuXi XDC (2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugate market; and Multitude Therapeutics, a clinical stage biotechnology company renowned for ADC platform technologies, announced today that they have reached a comprehensive partnership in drug-linker technology, which … Read more

Results of the Phase III INSPIRE Study on Qilu Pharmaceutical’s Iruplinalkib Published in the Journal of Thoracic Oncology

JINAN, China, Jan. 30, 2024 /PRNewswire/ — The interim analysis results from the phase III INSPIRE study of iruplinalkib developed by Qilu Pharmaceutical, which focuses on the first-line treatment of locally advanced or metastatic anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), have recently been featured in the Journal of Thoracic Oncology (Impact Factor=20.4), the … Read more

Dr. David Little and Dr. John Flucke Join CandidPro’s World-class Faculty

COLUMBUS, Ohio, Jan. 29, 2024 /PRNewswire/ — Candid, the company behind the revolutionary CandidPro clear aligner system, is opening 2024 with two more significant additions to its already impressive Candid Academy Faculty. David Little, DDS, and John Flucke, DDS, have agreed to bring their expertise and support to CandidPro. With these two industry powerhouses on board, … Read more